Compare NNNN & INGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NNNN | INGN |
|---|---|---|
| Founded | 2021 | 2001 |
| Country | Germany | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Industrial Specialties |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 163.7M | 177.0M |
| IPO Year | 2023 | 2013 |
| Metric | NNNN | INGN |
|---|---|---|
| Price | $3.81 | $7.09 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $12.00 |
| AVG Volume (30 Days) | 51.5K | ★ 328.3K |
| Earning Date | 11-03-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 43.42 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $348,668,000.00 |
| Revenue This Year | N/A | $2.22 |
| Revenue Next Year | N/A | $4.55 |
| P/E Ratio | $446.57 | ★ N/A |
| Revenue Growth | N/A | ★ 3.86 |
| 52 Week Low | $3.09 | $5.05 |
| 52 Week High | $44.73 | $8.94 |
| Indicator | NNNN | INGN |
|---|---|---|
| Relative Strength Index (RSI) | 31.81 | 75.54 |
| Support Level | $3.09 | $6.01 |
| Resistance Level | $6.95 | $7.55 |
| Average True Range (ATR) | 0.50 | 0.25 |
| MACD | 0.02 | 0.10 |
| Stochastic Oscillator | 28.99 | 93.79 |
Anbio Biotechnology is a medical device company focused on in vitro diagnostics. The company's mission is to change the diagnostics market by personalizing and decentralizing the current diagnostic solutions for faster diagnosis to improve patient prognosis. The company proposes this by providing accessible and affordable diagnostic solutions globally at the forefront of science and offering laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions. The business planning is to focus on validating and commercializing the existing portfolio of in vitro diagnostic products, as well as generating additional data required to support regulatory submissions and compliance, including under frameworks such as the In Vitro Diagnostic Regulation (IVDR).
Inogen Inc is a medical technology business that focuses on respiratory health. It develops, manufactures, and markets respiratory health products, including portable oxygen concentrators, or POCs, used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions and the Simeox product for airway clearance treatment. In addition, it has started distributing the Inogen Voxi 5 stationary oxygen concentrator as well as the Aurora continuous positive airway pressure, or CPAP, masks in the United States. The company derives revenues from customers through the development, manufacturing, marketing, sales, and rental of respiratory products.